These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9652728)

  • 1. Protection of leukemic cells by deoxycytidine: in vitro measures of protection against cytosine arabinoside.
    Cohen JD; Strock DJ; LaGuardia EA; Mao Z; Teik JE
    Leuk Res; 1998 May; 22(5):421-7. PubMed ID: 9652728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deoxycytidine in human plasma: potential for protecting leukemic cells during chemotherapy.
    Cohen JD; Strock DJ; Teik JE; Katz TB; Marcel PD
    Cancer Lett; 1997 Jun; 116(2):167-75. PubMed ID: 9215860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of intracellular metabolism of cytosine arabinoside in acute myeloid leukemia by granulocyte-macrophage colony-stimulating factor.
    Reuter C; Auf der Landwehr U; Schleyer E; Zühlsdorf M; Ameling C; Rolf C; Wörmann B; Büchner T; Hiddemann W
    Leukemia; 1994 Feb; 8(2):217-25. PubMed ID: 8309245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytosine arabinoside kills postmitotic neurons: evidence that deoxycytidine may have a role in neuronal survival that is independent of DNA synthesis.
    Wallace TL; Johnson EM
    J Neurosci; 1989 Jan; 9(1):115-24. PubMed ID: 2643680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytosine arabinoside kills postmitotic neurons in a fashion resembling trophic factor deprivation: evidence that a deoxycytidine-dependent process may be required for nerve growth factor signal transduction.
    Martin DP; Wallace TL; Johnson EM
    J Neurosci; 1990 Jan; 10(1):184-93. PubMed ID: 1688932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclopentenyl cytosine increases the phosphorylation and incorporation into DNA of 1-beta-D-arabinofuranosyl cytosine in a human T-lymphoblastic cell line.
    Verschuur AC; Van Gennip AH; Leen R; Voûte PA; Brinkman J; Van Kuilenburg AB
    Int J Cancer; 2002 Apr; 98(4):616-23. PubMed ID: 11920624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinically relevant deoxycytidine levels are high enough to profoundly alter 9-beta-D-arabinofuranosylguanine cytotoxicity for human T-cell acute leukemia cells in vitro.
    Cohen JD; Strock DJ; Teik JE; LaGuardia EA; Katz TB
    Pediatr Hematol Oncol; 1999; 16(3):239-44. PubMed ID: 10326222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of in vitro assays for detecting subpopulations of P388 leukemic cells resistant to AraC.
    Raza A; Kuliczkowski K; Weidong G; Preisler HD
    Med Oncol Tumor Pharmacother; 1984; 1(3):163-8. PubMed ID: 6544897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of drug synergism between the tyrosine kinase inhibitors NSC 680410 (adaphostin) and/or STI571 (imatinib mesylate, Gleevec) with cytotoxic drugs against human leukemia cell lines.
    Avramis IA; Laug WE; Sausville EA; Avramis VI
    Cancer Chemother Pharmacol; 2003 Oct; 52(4):307-18. PubMed ID: 12827297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular pharmacodynamic studies of the synergistic combination of 6-mercaptopurine and cytosine arabinoside in human leukemia cell lines.
    Ramilo-Torno LV; Avramis VI
    Cancer Chemother Pharmacol; 1995; 35(3):191-9. PubMed ID: 7805176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of antineoplastic activity of cytosine arabinoside and 5-aza-2'-deoxycytidine against human leukemic cells of different phenotype.
    Momparler RL; Onetto-Pothier N; Momparler LF
    Leuk Res; 1990; 14(9):755-60. PubMed ID: 1700231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytosine arabinoside transport and metabolism in acute leukemias and T cell lymphoblastic lymphoma.
    Wiley JS; Taupin J; Jamieson GP; Snook M; Sawyer WH; Finch LR
    J Clin Invest; 1985 Feb; 75(2):632-42. PubMed ID: 3871794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacodynamic basis for the increased antileukaemic efficacy of cytosine arabinoside-based treatment regimens in acute myeloid leukaemia with a high proliferative activity.
    Braess J; Voss S; Jahns-Streubel G; Schoch C; Haferlach T; Kern W; Keye S; Schleyer E; Hiddemann W
    Br J Haematol; 2000 Jul; 110(1):170-9. PubMed ID: 10930995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetrazolium (MTT) assay for cellular viability and activity.
    Morgan DM
    Methods Mol Biol; 1998; 79():179-83. PubMed ID: 9463833
    [No Abstract]   [Full Text] [Related]  

  • 15. Complementary antineoplastic activity of the cytosine nucleoside analogues troxacitabine (Troxatyl) and cytarabine in human leukemia cells.
    Bouffard DY; Jolivet J; Leblond L; Hamelin B; Ouellet F; Barbeau S; Richard A; Gourdeau H
    Cancer Chemother Pharmacol; 2003 Dec; 52(6):497-506. PubMed ID: 12955470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of deoxycytidine kinase in an in vitro model for AraC- and DAC-resistance: substrate-enzyme interactions with deoxycytidine, 1-beta-D-arabinofuranosylcytosine and 5-aza-2'-deoxycytidine.
    Stegmann AP; Honders MW; Kester MG; Landegent JE; Willemze R
    Leukemia; 1993 Jul; 7(7):1005-11. PubMed ID: 7686601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of anti-neoplastic activity of cytosine arabinoside against human HL-60 myeloid leukemic cells by 3-deazauridine.
    Momparler RL; Bouffard DY; Momparler LF; Marquet J; Zittoun J; Marie JP; Zittoun R
    Int J Cancer; 1991 Oct; 49(4):573-6. PubMed ID: 1917159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No preferential sensitivity of t(8;21) acute myeloid leukemias to cytosine arabinoside in vitro: is intensity of therapy or high dose Ara-C crucial for response?
    Visani G; Isidori A; Grafone T; Tosi P; Santini V; Malagola M; Martinelli G; Piccaluga PP; Gaziev D; Ottaviani E; Sparaventi G; Tura S
    Leuk Lymphoma; 2004 Jul; 45(7):1361-4. PubMed ID: 15359633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased accumulation of cytosine arabinoside in human leukemic cells and enhancement of its cell-killing activity by uridine.
    Takahashi I; Hayashi N; Nakamura T; Matuzaki T; Murase T; Osada K; Takeuchi M; Ueki Y; Nakada H; Yorimitsu S
    Acta Med Okayama; 1990 Dec; 44(6):329-31. PubMed ID: 2075831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of 4'-thio-beta-D-arabinofuranosylcytosine in CEM cells.
    Parker WB; Shaddix SC; Rose LM; Waud WR; Shewach DS; Tiwari KN; Secrist JA
    Biochem Pharmacol; 2000 Dec; 60(12):1925-32. PubMed ID: 11108809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.